These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28115188)

  • 1. Impact of G protein-coupled receptor heteromers in endocrine systems.
    Jonas KC; Hanyaloglu AC
    Mol Cell Endocrinol; 2017 Jul; 449():21-27. PubMed ID: 28115188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligomerization of GPCRs involved in endocrine regulation.
    Kleinau G; Müller A; Biebermann H
    J Mol Endocrinol; 2016 Jul; 57(1):R59-80. PubMed ID: 27151573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. History and biological significance of GPCR heteromerization in the neuroendocrine system.
    Tadagaki K; Jockers R; Kamal M
    Neuroendocrinology; 2012; 95(3):223-31. PubMed ID: 22156565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives.
    Ferré S; Casadó V; Devi LA; Filizola M; Jockers R; Lohse MJ; Milligan G; Pin JP; Guitart X
    Pharmacol Rev; 2014; 66(2):413-34. PubMed ID: 24515647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of heteromerization to G protein-coupled receptor function.
    Gaitonde SA; González-Maeso J
    Curr Opin Pharmacol; 2017 Feb; 32():23-31. PubMed ID: 27835800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the role of heteroreceptor complexes in the central nervous system.
    Fuxe K; Borroto-Escuela D; Fisone G; Agnati LF; Tanganelli S
    Curr Protein Pept Sci; 2014; 15(7):647. PubMed ID: 25256022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Techniques for Studying Oligomer Formations of G-Protein-Coupled Receptors Using Mammalian and Yeast Cells.
    Nakamura Y; Ishii J; Kondo A
    Curr Med Chem; 2016 May; 23(16):1638-56. PubMed ID: 27052183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minireview: Role of intracellular scaffolding proteins in the regulation of endocrine G protein-coupled receptor signaling.
    Walther C; Ferguson SS
    Mol Endocrinol; 2015 Jun; 29(6):814-30. PubMed ID: 25942107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring a role for heteromerization in GPCR signalling specificity.
    Rozenfeld R; Devi LA
    Biochem J; 2011 Jan; 433(1):11-8. PubMed ID: 21158738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moonlighting characteristics of G protein-coupled receptors: focus on receptor heteromers and relevance for neurodegeneration.
    Borroto-Escuela DO; Tarakanov AO; Guidolin D; Ciruela F; Agnati LF; Fuxe K
    IUBMB Life; 2011 Jul; 63(7):463-72. PubMed ID: 21698749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heteromerization of G protein-coupled receptors: relevance to neurological disorders and neurotherapeutics.
    Albizu L; Moreno JL; González-Maeso J; Sealfon SC
    CNS Neurol Disord Drug Targets; 2010 Nov; 9(5):636-50. PubMed ID: 20632964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPCR homomers and heteromers: a better choice as targets for drug development than GPCR monomers?
    Casadó V; Cortés A; Mallol J; Pérez-Capote K; Ferré S; Lluis C; Franco R; Canela EI
    Pharmacol Ther; 2009 Nov; 124(2):248-57. PubMed ID: 19664655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hardwiring wire-less networks: spatially encoded GPCR signaling in endocrine systems.
    Caengprasath N; Hanyaloglu AC
    Curr Opin Cell Biol; 2019 Apr; 57():77-82. PubMed ID: 30682696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G Protein-Coupled Receptor Multimers: A Question Still Open Despite the Use of Novel Approaches.
    Vischer HF; Castro M; Pin JP
    Mol Pharmacol; 2015 Sep; 88(3):561-71. PubMed ID: 26138074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPCR heteromers: An overview of their classification, function and physiological relevance.
    Dale NC; Johnstone EKM; Pfleger KDG
    Front Endocrinol (Lausanne); 2022; 13():931573. PubMed ID: 36111299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G-protein-coupled receptor type A heteromers as an emerging therapeutic target.
    Guidolin D; Agnati LF; Marcoli M; Borroto-Escuela DO; Fuxe K
    Expert Opin Ther Targets; 2015 Feb; 19(2):265-83. PubMed ID: 25381716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-protein-coupled receptor heteromer dynamics.
    Vilardaga JP; Agnati LF; Fuxe K; Ciruela F
    J Cell Sci; 2010 Dec; 123(Pt 24):4215-20. PubMed ID: 21123619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental strategies for studying G protein-coupled receptor homo- and heteromerization with radioligand binding and signal transduction methods.
    Maggio R; Rocchi C; Scarselli M
    Methods Enzymol; 2013; 521():295-310. PubMed ID: 23351746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Spatial Assembly of GPCRs Using Photoactivatable Dyes and Localization Microscopy.
    Jonas KC; Hanyaloglu AC
    Methods Mol Biol; 2019; 1947():337-348. PubMed ID: 30969426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular integration via allosteric interactions in receptor heteromers. A working hypothesis.
    Fuxe K; Marcellino D; Leo G; Agnati LF
    Curr Opin Pharmacol; 2010 Feb; 10(1):14-22. PubMed ID: 19942481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.